Fig. 2From: Functional improvement assessed by multifocal electroretinogram after Ocriplasmin treatment for vitreomacular tractionTime courses of BCVA over the 6-month follow-up. In the first three patients BCVA, following an initial decline, improved after the release of VMT; in the last patient the BCVA remained stable (20/20) over all the follow-upBack to article page